Violation Tracker Individual Record
Date:December 20, 2013
Offense Group:government-contracting-related offenses
Primary Offense:False Claims Act and related
Genzyme Corp. agreed to pay $22.28 million to resolve allegations that it marketed, and caused false claims to be submitted to federal and state health care programs for use of, a "slurry" version of its Seprafilm adhesion barrier.
Level of Government:federal
Action Type:agency action
Agency:Justice Department Civil Division
Civil or Criminal Case:civil
HQ Country of Parent:France
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.